Senescent CD8+ T and NK cells contribute to immunopathogy duting cutaneous leishmaniasis
衰老的 CD8 T 和 NK 细胞导致皮肤利什曼病的免疫病理
基本信息
- 批准号:MR/T015853/1
- 负责人:
- 金额:$ 93.31万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Parasites belonging to the genus Leishmania are among the most diverse of human pathogens, both in terms of geographical distribution and in the variety of clinical syndromes caused by them. Currently, 12 million people are infected worldwide in 88 tropical/subtropical countries, 2 million new infections are reported annually, and 350 million people are under infection risk. In the past decade, the number of cases in endemic areas has increased sharply. In addition, leishmaniasis is spreading to several non-endemic areas of the world due to coinfections with HIV. Control measures currently available are case detection and treatment with drugs, which are expensive, not always available and cannot be self-administered. The problem is further aggravated by the surge of drug resistance parasites necessitating the development of an anti-Leishmania vaccine or other immunological therapies urgent.Research has demonstrated the importance of the immunity in controlling both cutaneous and mucocutaneous leishmaniasis, however the severe skin lesions that develop at the infected site is largely due to non-specific tissue damage but the reasons for this are unclear. The majority of this work has been performed on blood samples taken from patients and not from the site of infection at the skin. In this context, a unique feature of the current proposal is that we will be investigating the blood as well as the skin from the same patients, taken from both lesional and non-lesional sites. The main hypothesis of this grant application is that the severity of cutaneous immunopathology in infected individuals is due to non-specific damage mediated by both two types of immune cell namely the natural killer (NK) cells and a type of T cell that represent the "Dad's Army" of the immune system. Both these cell types are probably not triggered by the parasite in the skin lesions, instead they recognize decoy molecules in non-infected skin cells that cause them to be destroyed. This results in the large skin lesions that contain few parasites but huge numbers of dangerous white cells. In this study we will investigate the nature of the white cells in the skin lesions of patients. We will identify the decoy receptors that promote the non-specific tissue damage. We will also look at the wide array of genes that are activated in the skin to identify clue of how the interactions between the immune system and the skin are organized. We will also identify genes that will give us clues as to what other processes may be occurring that do not allow the lesions to resolve. In other parts of the study we will mimic the interaction of cell that are in the skin by growing them in a test tube to probe their interactions and find a way to block them. Finally we will investigate the involvement of a set off molecules known as sestrins, that we previously showed were involved in setting up the decoy mechanisms that may lead to skin lesion formation in patients with cutaneous leishmaniasis.As added value to this proposal, The Federal University of Espirito Santo will contribute 1 Technician and 1 PhD student to work on aspects of this grant.
属于利什曼原虫属的寄生虫是人类病原体中最多样化的寄生虫,无论是在地理分布和由其引起的临床综合症的种类方面。目前,在88个热带/亚热带国家中,全世界有1,200万人被感染,每年有200万新的感染,3.5亿人受感染风险。在过去的十年中,地方性地区的案件数量急剧增加。此外,由于与艾滋病毒的共同感染,利什曼病正在扩散到世界上几个非流行地区。当前可用的控制措施是用药物检测和治疗,这些药物很昂贵,并不总是可用,不能自我管理。抗药性寄生虫的激增需要开发抗leishmania疫苗或其他免疫学疗法,这进一步加剧了问题。研究表明,免疫在控制皮肤和毛状眼皮术和粘膜胶质性利什玛病中的重要性,但是由于受感染而导致的严重皮肤病变是不受特征性的损害,但要损害了该部位的特定性,但损害了特定的特征。这项工作的大部分是针对从患者而不是从皮肤感染部位采集的血液样本进行的。在这种情况下,当前提案的一个独特特征是,我们将研究来自病变和非静态部位的同一患者的血液以及同一患者的皮肤。该赠款应用的主要假设是,受感染个体的皮肤免疫病理学的严重程度是由于两种免疫细胞介导的非特异性损害,即自然杀伤剂(NK)细胞(NK)细胞和代表免疫系统的“爸爸军”的一种T细胞。这两种细胞类型可能不是由皮肤病变中的寄生虫触发的,而是识别未感染的皮肤细胞中的诱饵分子,导致它们被破坏。这导致较大的皮肤病变含有很少的寄生虫,但大量危险的白细胞。在这项研究中,我们将研究患者皮肤病变中白细胞的性质。我们将确定诱导非特异性组织损伤的诱饵受体。我们还将研究在皮肤中激活的各种基因,以识别免疫系统与皮肤之间如何组织相互作用的线索。我们还将确定将为我们提供有关其他过程可能不允许病变解决的基因。在研究的其他部分,我们将通过在试管中种植它们来探测它们的相互作用并找到阻止它们的方法来模仿皮肤中细胞的相互作用。最后,我们将研究一个称为sestrins的分子的参与,我们先前表明的参与了可能导致皮肤利什曼病的患者的皮肤病变形成的诱饵机制。由于该提案的增加价值,Espirito Santo联邦大学将贡献1名技术人员和1名PHD学生,从而在该方面工作。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology.
皮肤利什曼病皮肤病变的转录组学景观揭示了与免疫病理学相关的强烈 CD8 T 细胞免疫衰老特征。
- DOI:10.1111/imm.13410
- 发表时间:2021
- 期刊:
- 影响因子:6.4
- 作者:Fantecelle CH
- 通讯作者:Fantecelle CH
Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait
- DOI:10.1093/cei/uxad074
- 发表时间:2023-12-11
- 期刊:
- 影响因子:4.6
- 作者:Ligotti,Mattia Emanuela;Accardi,Giulia;Candore,Giuseppina
- 通讯作者:Candore,Giuseppina
PD-1 Blockade Modulates Functional Activities of Exhausted-Like T Cell in Patients With Cutaneous Leishmaniasis.
- DOI:10.3389/fimmu.2021.632667
- 发表时间:2021
- 期刊:
- 影响因子:7.3
- 作者:Garcia de Moura R;Covre LP;Fantecelle CH;Gajardo VAT;Cunha CB;Stringari LL;Belew AT;Daniel CB;Zeidler SVV;Tadokoro CE;de Matos Guedes HL;Zanotti RL;Mosser D;Falqueto A;Akbar AN;Gomes DCO
- 通讯作者:Gomes DCO
The role of senescent T cells in immunopathology.
- DOI:10.1111/acel.13272
- 发表时间:2020-12
- 期刊:
- 影响因子:7.8
- 作者:Covre LP;De Maeyer RPH;Gomes DCO;Akbar AN
- 通讯作者:Akbar AN
Senescent T cells: Beneficial and detrimental roles
- DOI:10.1111/imr.13206
- 发表时间:2023-04-25
- 期刊:
- 影响因子:8.7
- 作者:Laphanuwat,Phatthamon;Gomes,Daniel Claudio Oliveira;Akbar,Arne N.
- 通讯作者:Akbar,Arne N.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arne Akbar其他文献
Time-restricted eating reveals a “younger” immune system and reshapes the intestinal microbiome in human
- DOI:
10.1016/j.redox.2024.103422 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Yiran Chen;Xi Li;Ming Yang;Chen Jia;Zhenghao He;Suqing Zhou;Pinglang Ruan;Yikun Wang;Congli Tang;Wenjing Pan;Hai Long;Ming Zhao;Liwei Lu;Weijun Peng;Arne Akbar;Irene XY. Wu;Song Li;Haijing Wu;Qianjin Lu - 通讯作者:
Qianjin Lu
Arne Akbar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arne Akbar', 18)}}的其他基金
Mechanism for CD8+ T cell recognition and removal of senescent tissue cells during ageing
衰老过程中CD8 T细胞识别和清除衰老组织细胞的机制
- 批准号:
BB/Y003365/1 - 财政年份:2024
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Establishing a network to catalyse collaboration for reducing immune ageing (CARINA: CAtalyst Reducing ImmuNe Ageing)
建立网络以促进合作以减少免疫衰老(CARINA:CATalyst Reducing ImmuNe Ageing)
- 批准号:
BB/W018225/1 - 财政年份:2022
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
How does blocking inflammation enhance human cutaneous immunity during ageing in vivo?
阻断炎症如何增强体内衰老过程中的人体皮肤免疫力?
- 批准号:
MR/T030534/1 - 财政年份:2020
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Characterization of Leishmania-Specific T cells in human skin and blood during cutaneous and mucocutaneous leishmaniasis
皮肤和粘膜皮肤利什曼病期间人体皮肤和血液中利什曼原虫特异性 T 细胞的表征
- 批准号:
MR/N017749/1 - 财政年份:2016
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
The integration of human T cell senescence and function at the molecular level
人类T细胞衰老与功能在分子水平上的整合
- 批准号:
MR/P00184X/1 - 财政年份:2016
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
MICA: Suppressing inflammation to enhance antigen-specific immunity in older humans using p38MAPK inhibitors and vitaminD3
MICA:使用 p38MAPK 抑制剂和维生素 D3 抑制炎症以增强老年人的抗原特异性免疫力
- 批准号:
MR/M003833/1 - 财政年份:2015
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
The functional and migratory characteristics of low avidity virus-specific T cells during ageing
衰老过程中低亲和力病毒特异性T细胞的功能和迁移特征
- 批准号:
BB/L005336/1 - 财政年份:2014
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
International Partnering Award with the USA to investigate signalling pathways that regulate human immunity during ageing
与美国合作研究在衰老过程中调节人体免疫力的信号通路
- 批准号:
BB/L025302/1 - 财政年份:2014
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Reversing senescence and exhaustion signalling pathways in primary human T lymphocytes during ageing
逆转衰老过程中人原代 T 淋巴细胞的衰老和耗竭信号通路
- 批准号:
BB/J006750/1 - 财政年份:2012
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
Mechanisms of reduced T cell imunity in older adults
老年人 T 细胞免疫力降低的机制
- 批准号:
BB/H020519/1 - 财政年份:2010
- 资助金额:
$ 93.31万 - 项目类别:
Research Grant
相似国自然基金
Wip1/AP-1通路介导的CD8+/CD122+ Treg分化在移植排斥中的作用及机制研究
- 批准号:82302004
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CD40/CD40L通路激活CD8+毒性T淋巴细胞调控TED眼眶组织重塑的机制研究
- 批准号:82371105
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于C/EBPβ/P2X7R通路调节CD8+ Teff/Treg平衡探讨滨蒿内酯抑制移植排斥反应的分子机制
- 批准号:82302006
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
树突状细胞高表达SHP1通过抑制CD8+记忆性T细胞增强乳腺癌免疫逃逸的机制研究
- 批准号:82304532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
敲减THOC1通过R loops促进肝细胞癌中CD8+ T细胞浸润并逆转其耗竭的机制研究
- 批准号:82304515
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 93.31万 - 项目类别:
Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer
CD206 TAM 的治疗靶向增强转移性去势抵抗性前列腺癌的适应性和先天抗肿瘤免疫反应
- 批准号:
10731906 - 财政年份:2023
- 资助金额:
$ 93.31万 - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
$ 93.31万 - 项目类别:
The role of CMV in HIV-associated accentuated aging
CMV 在 HIV 相关的加速衰老中的作用
- 批准号:
10760596 - 财政年份:2023
- 资助金额:
$ 93.31万 - 项目类别:
Combining Radiation, Allogeneic Natural Killer Immunotherapy, and PD-L1 blockade in Dogs with Naturally-Occurring Melanoma
结合放疗、同种异体自然杀伤免疫疗法和 PD-L1 阻断治疗患有天然黑色素瘤的狗
- 批准号:
10679952 - 财政年份:2023
- 资助金额:
$ 93.31万 - 项目类别: